Consolidation Therapy with Checkpoint Inhibitors After Autologous Hematopoietic Cell Transplantation in Patients with High-Risk Multiple Myeloma and Lymphoma

Lindsay Fogel; Patrick C. Roney; Jaeil Ahn; Joshua Zenreich; Adolfo Aleman; Kimberly Doucette; Palka Anand; Andrew Ip; Andre Goy; Tatyana Feldman; Lori Leslie; Andrew Pecora; Pooja Phull; Harsh Parmar; David Vesole; David S. Siegel; Noa Biran

doi:10.1016/j.jtct.2026.04.056

Consolidation Therapy with Checkpoint Inhibitors After Autologous Hematopoietic Cell Transplantation in Patients with High-Risk Multiple Myeloma and Lymphoma

Lindsay Fogel
, Patrick C. Roney
, Jaeil Ahn
, Joshua Zenreich
, Adolfo Aleman
, Kimberly Doucette
, Palka Anand
, Andrew Ip
, Andre Goy
, Tatyana Feldman
, Lori Leslie
, Andrew Pecora
, Pooja Phull
, Harsh Parmar
, David Vesole
, David S. Siegel
, Noa Biran

School of Medicine

Hackensack Meridian School of Medicine
Georgetown University
Hackensack Meridian Health

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1078.e1-1078.e4
Journal	Transplantation and Cellular Therapy
Volume	32
Issue number	9
DOIs	https://doi.org/10.1016/j.jtct.2026.04.056
State	Published - Sep 2026

Keywords

Checkpoint inhibitor
High-risk
Multiple myeloma
T-cell lymphoma
non-Hodgkin lymphoma

Access to Document

10.1016/j.jtct.2026.04.056

Cite this

Fogel, L., Roney, P. C., Ahn, J., Zenreich, J., Aleman, A., Doucette, K., Anand, P., Ip, A., Goy, A., Feldman, T., Leslie, L., Pecora, A., Phull, P., Parmar, H., Vesole, D., Siegel, D. S., & Biran, N. (2026). Consolidation Therapy with Checkpoint Inhibitors After Autologous Hematopoietic Cell Transplantation in Patients with High-Risk Multiple Myeloma and Lymphoma. Transplantation and Cellular Therapy, 32(9), 1078.e1-1078.e4. https://doi.org/10.1016/j.jtct.2026.04.056

@article{6453f4109b7d47b5b1798a377db1ce58,

title = "Consolidation Therapy with Checkpoint Inhibitors After Autologous Hematopoietic Cell Transplantation in Patients with High-Risk Multiple Myeloma and Lymphoma",

keywords = "Checkpoint inhibitor, High-risk, Multiple myeloma, T-cell lymphoma, non-Hodgkin lymphoma",

author = "Lindsay Fogel and Roney, \{Patrick C.\} and Jaeil Ahn and Joshua Zenreich and Adolfo Aleman and Kimberly Doucette and Palka Anand and Andrew Ip and Andre Goy and Tatyana Feldman and Lori Leslie and Andrew Pecora and Pooja Phull and Harsh Parmar and David Vesole and Siegel, \{David S.\} and Noa Biran",

year = "2026",

month = sep,

doi = "10.1016/j.jtct.2026.04.056",

language = "English",

volume = "32",

pages = "1078.e1--1078.e4",

journal = "Transplantation and Cellular Therapy",

issn = "2666-6375",

publisher = "Elsevier B.V.",

number = "9",

}

Fogel, L, Roney, PC, Ahn, J, Zenreich, J, Aleman, A, Doucette, K, Anand, P, Ip, A , Goy, A , Feldman, T , Leslie, L , Pecora, A , Phull, P , Parmar, H , Vesole, D , Siegel, DS & Biran, N 2026, 'Consolidation Therapy with Checkpoint Inhibitors After Autologous Hematopoietic Cell Transplantation in Patients with High-Risk Multiple Myeloma and Lymphoma', Transplantation and Cellular Therapy, vol. 32, no. 9, pp. 1078.e1-1078.e4. https://doi.org/10.1016/j.jtct.2026.04.056

TY - JOUR

T1 - Consolidation Therapy with Checkpoint Inhibitors After Autologous Hematopoietic Cell Transplantation in Patients with High-Risk Multiple Myeloma and Lymphoma

AU - Fogel, Lindsay

AU - Roney, Patrick C.

AU - Ahn, Jaeil

AU - Zenreich, Joshua

AU - Aleman, Adolfo

AU - Doucette, Kimberly

AU - Anand, Palka

AU - Ip, Andrew

AU - Goy, Andre

AU - Feldman, Tatyana

AU - Leslie, Lori

AU - Pecora, Andrew

AU - Phull, Pooja

AU - Parmar, Harsh

AU - Vesole, David

AU - Siegel, David S.

AU - Biran, Noa

PY - 2026/9

Y1 - 2026/9

KW - Checkpoint inhibitor

KW - High-risk

KW - Multiple myeloma

KW - T-cell lymphoma

KW - non-Hodgkin lymphoma

UR - https://www.scopus.com/pages/publications/105041184894

U2 - 10.1016/j.jtct.2026.04.056

DO - 10.1016/j.jtct.2026.04.056

M3 - Article

C2 - 42140559

AN - SCOPUS:105041184894

SN - 2666-6375

VL - 32

SP - 1078.e1-1078.e4

JO - Transplantation and Cellular Therapy

JF - Transplantation and Cellular Therapy

IS - 9

ER -

Consolidation Therapy with Checkpoint Inhibitors After Autologous Hematopoietic Cell Transplantation in Patients with High-Risk Multiple Myeloma and Lymphoma

Keywords

Access to Document

Other files and links

Cite this